Select a section from the left sidebar
Methyl 8-oxononanoate
- Family: Plantae - Chenopodiaceae
- Kingdom: Plantae
- Class: Fatty Acid
Canonical Smiles | COC(=O)CCCCCCC(=O)C |
---|---|
InChI | InChI=1S/C10H18O3/c1-9(11)7-5-3-4-6-8-10(12)13-2/h3-8H2,1-2H3 |
InChIKey | VEGNIXGAQNVYTP-UHFFFAOYSA-N |
Formula | C10H18O3 |
HBA | 3 |
HBD | 0 |
MW | 186.25 |
Rotatable Bonds | 7 |
TPSA | 43.37 |
LogP | 2.09 |
Number Rings | 0 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Fraction CSP3 | 0.8 |
Exact Mass | 186.13 |
Number of Lipinski Rule Violations | 0 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Haloxylon scoparium | Chenopodiaceae | Plantae | 1665493 |
Showing of synonyms
Methyl 8-oxononanoate
34455-70-4
DTXSID70337097
DTXCID60288185
Vegnixgaqnvytp-uhfffaoysa-n
Methyl 8-oxo-nonanoate
SCHEMBL3626724
AT40179
DA-06616
No compound-protein relationship available.
No scaffolds available.
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -4.38
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -4.000
- Human Oral Bioavailability 50%
- Non-Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -2.89
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 0.200
- Plasma Protein Binding
- 18.59
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Inhibitor
- CYP 1A2 Substrate
- Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Non-Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 8.870
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- 0.750
- Biodegradation
- Toxic
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Toxic
- Eye Irritation
- Toxic
- Maximum Tolerated Dose
- 1.570
- Liver Injury II
- Safe
- hERG Blockers
- Safe
- Daphnia Maga
- 3.490
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- 2.760
- Rat (Acute)
- 1.500
- Rat (Chronic Oral)
- 2.010
- Fathead Minnow
- 3.870
- Respiratory Disease
- Safe
- Skin Sensitisation
- Toxic
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 253.650
- Hydration Free Energy
- -5.150
- Log(D) at pH=7.4
- 1.240
- Log(P)
- 1.5
- Log S
- -1.87
- Log(Vapor Pressure)
- -1.86
- Melting Point
- 10.58
- pKa Acid
- 12.73
- pKa Basic
- 6.83
No predicted protein targets found for this compound.